Sign in
Enrolling by invitationNo phase

Tests a tube feeding formula for weight loss in obese people fed by tube

Tests a low-calorie, high-protein tube feeding formula in adults with obesity.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
Evaluating Benefit of Peptide Based Diet in Obese HEN Patients
Status
Enrolling by invitation
People taking part
12 people, planned
Started
25 Mar 2023
Expected to end
Dec 2027
Type of study
Interventional
Treatments tested
  • Peptamen Intense VHP, Nestlé Health Science, Switzerland
Record updated
26 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obesity who get most of their nutrition through a feeding tube at home and have had a stroke.

Age
18 years or older
Sex
All sexes can join.
Disease stage
BMI over 30, history of stroke, on home tube feeding that gives at least 90% of energy needs.
Earlier treatment
Weight must have been stable over the past month.

Main reasons for not taking part

  • Cancer with active treatment (chemotherapy, radiation, immunotherapy)
  • Life expectancy of less than 6 months
  • Stage IV or higher kidney disease (GFR < 30)

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Home Enteral Nutrition (HEN) patient receiving at least 90% of energy needs from enteral nutrition
  • BMI > 30
  • History of stroke
  • Weight stable over the past month

Who cannot take part

  • Diagnosis of cancer undergoing active treatment (chemotherapy, radiation, immunotherapy)
  • Stage IV or higher kidney disease (GFR < 30)
  • Life expectancy of less than 6 months

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of this study is to assess the effects of a low energy, high protein tube feeding formula on body weight in tube fed patients who are obese. It will also assess study formula tolerance as well as impact of the study formula on lean body mass, blood pressure, blood sugar and lipids.

The group in the trial

  • Peptamen Intense in obese home enteral nutrition patients after strokeTreatment being tested

    Subjects currently enrolled in Mayo Clinic Home Enteral Nutrition (HEN) program and anticipated to require tube feedings to provide 90% or more of feeding needs will be placed on a Peptamen Intense VHP for up to 12 weeks.

    Treatment: Peptamen Intense VHP, Nestlé Health Science, Switzerland

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effect of Hypocaloric, High-protein Enteral Formula on Body Weight and Health Outcomes in Obese HEN Patients: A Pilot Study
Plain-language title
Tests a tube feeding formula for weight loss in obese people fed by tubeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
26 January 2026